Publication | Open Access

Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial

Regenerative MedicineGene TherapiesTranslational MedicineOcular DiseaseOphthalmologyAge-related DiseasesRecombinant Adeno-associated VectorsGene VectorNeovascularizationRetinal TherapiesMedicineRadiation OncologyPhase 1Novel TherapyHealth Sciences